
SOLEUS CAPITAL MANAGEMENT, L.P.
Latest 13F filing data - Q4 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | GERN | 23.29M | $30.74M |
![]() | IKT | 10.88M | $22.29M |
![]() | ORGO | 9.99M | $51.73M |
![]() | NVCR | 8.53M | $110.30M |
![]() | IVVD | 7.71M | $19.04M |
![]() | EDAP | 7.31M | $24.05M |
![]() | FOLD | 5.21M | $74.15M |
![]() | CERS | 4.00M | $8.24M |
![]() | CCCC | 3.80M | $7.27M |
![]() | TGTX | 3.14M | $93.58M |
![]() | NPCE | 2.70M | $41.74M |
![]() | BBNX | 2.53M | $77.23M |
![]() | SNDX | 2.25M | $47.21M |
![]() | ERAS | 2.16M | $8.04M |
![]() | LUNG | 2.04M | $4.50M |
![]() | TWST | 1.86M | $59.06M |
![]() | CELC | 1.81M | $180.36M |
![]() | ALKS | 1.32M | $37.00M |
![]() | BMRN | 1.32M | $78.45M |
![]() | DXCM | 1.30M | $86.09M |

Geron Corporation
GERN
Shares Held
23.29M
Value
$30.74M

Inhibikase Therapeutics, Inc.
IKT
Shares Held
10.88M
Value
$22.29M

Organogenesis Holdings Inc.
ORGO
Shares Held
9.99M
Value
$51.73M

NovoCure Limited
NVCR
Shares Held
8.53M
Value
$110.30M

Invivyd, Inc.
IVVD
Shares Held
7.71M
Value
$19.04M

Edap Tms S.a.
EDAP
Shares Held
7.31M
Value
$24.05M

Amicus Therapeutics, Inc.
FOLD
Shares Held
5.21M
Value
$74.15M

Cerus Corporation
CERS
Shares Held
4.00M
Value
$8.24M

C4 Therapeutics, Inc.
CCCC
Shares Held
3.80M
Value
$7.27M

TG Therapeutics, Inc.
TGTX
Shares Held
3.14M
Value
$93.58M

NeuroPace, Inc.
NPCE
Shares Held
2.70M
Value
$41.74M

Beta Bionics, Inc.
BBNX
Shares Held
2.53M
Value
$77.23M

Syndax Pharmaceuticals, Inc.
SNDX
Shares Held
2.25M
Value
$47.21M

Erasca, Inc.
ERAS
Shares Held
2.16M
Value
$8.04M

Pulmonx Corporation
LUNG
Shares Held
2.04M
Value
$4.50M

Twist Bioscience Corporation
TWST
Shares Held
1.86M
Value
$59.06M

Celcuity Inc.
CELC
Shares Held
1.81M
Value
$180.36M

Alkermes plc
ALKS
Shares Held
1.32M
Value
$37.00M

BioMarin Pharmaceutical Inc.
BMRN
Shares Held
1.32M
Value
$78.45M

DexCom, Inc.
DXCM
Shares Held
1.30M
Value
$86.09M
